Broad-spectrum extract has very low THC content, far below that of full-spectrum hemp. I first developed broad-spectrum hemp products five or six years ago, in the infancy of the pet CBD craze. It was an important way to ensure the safety of these extracts for use with dogs. Over time, we’ve placed 500,000+ units of various products into the hands of veterinarians, and anecdotal reports indicate that there has been minimal to zero adverse reactions to the THC content of these formulations and no perceived diminution of efficacy for osteoarthritis, epilepsy and anxiety, the three most dominant applications for pet CBD.
However, anecdotal evidence is not the same as unbiased, placebo-controlled, blinded research into a product’s efficacy. To this end, we are in the middle of a study at a veterinary rehab hospital in Austin, Texas, to measure the efficacy of our broad-spectrum extract in naturally occurring osteoarthritis in dogs.
via Whisker Therapy